(19)
(11) EP 1 682 493 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.11.2009 Bulletin 2009/48

(45) Mention of the grant of the patent:
07.01.2009 Bulletin 2009/02

(21) Application number: 04797665.9

(22) Date of filing: 05.11.2004
(51) International Patent Classification (IPC): 
C07C 255/29(2006.01)
A01N 37/34(2006.01)
 C07C 255/54(2006.01)
(86) International application number:
PCT/EP2004/012559
(87) International publication number:
WO 2005/044784 (19.05.2005 Gazette 2005/20)

(54)

AMIDOACETONITRILE DERIVATIVES

AMIDOACETONITRILDERIVATE

DERIVES D'AMIDOACETONITRILE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 06.11.2003 EP 03025290
06.02.2004 GB 0402677

(43) Date of publication of application:
26.07.2006 Bulletin 2006/30

(73) Proprietors:
  • Novartis AG
    4056 Basel (CH)
    Designated Contracting States:
    IT IS IE HU GR GB FR FI ES EE DK DE CZ CY LI CH BG BE LU MC NL PL PT RO SE SI SK TR 
  • Novartis Pharma GmbH
    1230 Wien (AT)
    Designated Contracting States:
    AT 

(72) Inventors:
  • GAUVRY, Noëlle
    F-68680 Kembs-Loechle (FR)
  • GOEBEL, Thomas
    79539 Lörrach (DE)
  • DUCRAY, Pierre
    F-68128 Village-Neuf (FR)
  • PAUTRAT, François
    F-68100 Mulhouse (FR)
  • KAMINSKY, Ronald
    CH-1789 Lugnorre (CH)
  • JUNG, Martin
    CH-1586 Vallamand-Dessus (CH)

(74) Representative: de Weerd, Petrus G.W. et al
Novartis Animal Health, Inc. Patent and Trademark Group Werk Rosental
4002 Basel
4002 Basel (CH)


(56) References cited: : 
EP-A- 0 953 565
FR-A- 1 441 499
 WO-A-03/104187
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).